Canada Animal Drug Compounding Market Size & Outlook, 2030

Revenue, 2022 (US$M)

$89.9

Forecast, 2030 (US$M)

$173.6

CAGR, 2023 - 2030

8.6%

Report Coverage

Canada

Canada animal drug compounding market, 2018-2030 (US$M)

Global Animal Drug Compounding Industry Outlook

North America Animal Drug Compounding Market Outlook

U.S. Animal Drug Compounding Market Outlook

Europe Animal Drug Compounding Market Outlook

Germany Animal Drug Compounding Market Outlook

France Animal Drug Compounding Market Outlook

Italy Animal Drug Compounding Market Outlook

Spain Animal Drug Compounding Market Outlook

UK Animal Drug Compounding Market Outlook

Asia Pacific Animal Drug Compounding Market Outlook

Japan Animal Drug Compounding Market Outlook

China Animal Drug Compounding Market Outlook

India Animal Drug Compounding Market Outlook

Australia Animal Drug Compounding Market Outlook

South Korea Animal Drug Compounding Market Outlook

Latin America Animal Drug Compounding Market Outlook

Mexico Animal Drug Compounding Market Outlook

Brazil Animal Drug Compounding Market Outlook

MEA Animal Drug Compounding Market Outlook

South Africa Animal Drug Compounding Market Outlook

Saudi Arabia Animal Drug Compounding Market Outlook

The Canada animal drug compounding market generated a revenue of USD 89.9 million in 2022 and is expected to reach USD 173.6 million by 2030.
The Canada market is expected to grow at a CAGR of 8.6% from 2023 to 2030.
In terms of segment, oral was the largest revenue generating route of administration in 2022.
Topical is the most lucrative route of administration segment registering the fastest growth during the forecast period.

Market revenue in 2022	USD 89.9 million
Market revenue in 2030	USD 173.6 million
Growth rate	8.6% (CAGR from 2022 to 2030)
Largest segment	Oral
Fastest growing segment	Topical
Historical data	2018 - 2021
Base year	2022
Forecast period	2023 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Oral, Injectable, Topical, Other Routes
Key market players worldwide	Partners Group Holding AG, Vimian Group AB, Pharmaca, Akina, Triangle Compounding Pharmacy, Central Compounding Pharmacy, Wellness Compounding Pharmacy, Miller Pharmacy

In terms of revenue, Canada accounted for 6.8% of the global animal drug compounding market in 2022.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In North America, U.S. animal drug compounding market is projected to lead the regional market in terms of revenue in 2030.
Canada is the fastest growing regional market in North America and is projected to reach USD 173.6 million by 2030.